Can I read ESMO 2022 EGFR Mutant Non-Small-Cell Lung Cancer 2 on EtoBox?
ESMO 2022 EGFR Mutant Non-Small-Cell Lung Cancer 2 by EDWIN WIJAYA is a document available to read on EtoBox.
What is ESMO 2022 EGFR Mutant Non-Small-Cell Lung Cancer 2 about?
The document discusses the need to accurately identify all clinically relevant EGFR mutations in NSCLC patients, including both common and uncommon mutations. It also recommends performing a tissue rebiopsy when feasible for patients progressing on EGFR TKI therapy to assess resistance mechanisms and potential histologic transformation.
- Author
- EDWIN WIJAYA
- Language
- EN